Knight Therapeutics Inc.
Profile
Mailing Address: 3400 De Maisonneuve West
Suite 1055
Montréal, Québec
H3Z 3B8
Head Office Address: 3400 De Maisonneuve West
Suite 1055
Montréal, Québec
H3Z 3B8
Contact Name: Samira Sakhia Principal Regulator: Quebec
Business e-mail address: ssakhia@gud-knight.com Short Form Prospectus Issuer: Yes
Telephone Number: 514 484-4483 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland
Fax Number: 514 481-4116 Stock Exchange: TSX
Date of Formation: Nov 1 2013 Stock Symbol: GUD
Jurisdiction Where Formed: Canada Auditor: Ernst & Young
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 499053 Transfer Agent: AST Trust Company (Canada)
Financial Year-End: Dec 31 Size of Issuer (Assets): $500,000,001 to $1,000,000,000


View This Company's Documents